Belgian atopic dermatitis guidelines

Hilde Lapeere, Reinhart Speeckaert, Marie Baeck, Bita Dezfoulian, Julien Lambert, Pierre-Paul Roquet-Gravy, Annelies Stockman, Jonathan White, Francisca Castelijns, Jan Gutermuth

Research output: Contribution to journalArticlepeer-review


Atopic dermatitis (AD) is one of the most common, bothersome and difficult to treat skin disorders. Recent introduction of new systemic treatments has revolutionized the management of AD. The goal of this guideline is to provide evidence-based recommendations for the management of patients suffering from atopic dermatitis that easily can be implemented in clinical practice. These recommendations were developed by 11 Belgian AD experts. Comments of all experts on the proposed statements were gathered, followed by an online voting session. The most relevant strategies for the management and treatment of AD in the context of the Belgian health care landscape are discussed. General measures, patient education and adequate topical treatment remain the cornerstones of AD management. For moderate to severe AD, the introduction of biologics and JAK inhibitors show unprecedented efficacy, although currently access is limited to a subgroup of patients meeting the reimbursement criteria.

Original languageEnglish
Pages (from-to)62-74
Number of pages13
JournalActa Clinica Belgica
Issue number1
Publication statusPublished - Feb 2024

Bibliographical note

Funding Information:
for the project was provided to the Royal Belgian Society of Dermatology and Venerology by six pharmaceutical companies: Celgene, Eli Lilly, Janssen, LEO Pharma, Novartis and UCB. These companies were, however, not involved in the making of the manuscript.

Publisher Copyright:
© Belgian Society of Internal Medicine and Royal Belgian Society of Laboratory Medicine (2023).


  • Humans
  • Dermatitis, Atopic/drug therapy
  • Belgium
  • Administration, Cutaneous


Dive into the research topics of 'Belgian atopic dermatitis guidelines'. Together they form a unique fingerprint.

Cite this